【ChiCTR1800016588】Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
ChiCTR1800016588
正在进行
/
/
/
2018-06-11
/
/
孤獨症譜系障礙
Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
The objective of this randomized controlled trial is to examine the effectiveness of a mindfulness-based intervention specifically developed for children with ASD aged 8 to 18 years on their well-being, autism-related symptoms, behaviours, resilience, family relationship, mindfulness level and health service utilization, as well as their parents parental stress, well being, rumination, and health service utilization in Hong Kong, comparing to waiting list control.
随机平行对照
治疗新技术
The randomisation will be conducted by an experienced independent statistician using computer-generated random results.
Participants will be informed of their group assignments. The research staff member who conducts the assessments or the statistical analysis will be kept blinded of the group assignment.
The D. H. Chen Foundation, Hong Kong SAR
/
140
/
2018-06-28
2021-06-27
/
Participants will include both children with ASD and their parents. The inclusion criteria will be (1) children aged 8-18 years who have been previously diagnosed with ASD by a doctor according to the Diagnostic and Statistical Manual of Mental Disorders-4/5 (DSM-4/5) diagnostic criteria; (2) and at least one of their parents agrees to participate.；
请登录查看The exclusion criteria will be: (1) being unable to communicate and understand Chinese language as the intervention will be conducted in Chinese; (2) having a medical condition rendering him/her to be incapable to participate in the study; (3) unwilling or unable to give consent.；
请登录查看The D. H. Chen Foundation, Hong Kong SAR
/
The D. H. Chen Foundation, Hong Kong SAR的其他临床试验
- Mindfulness-based intervention for children/youth with internalizing problems and their families: a pilot study
- Mindfulness based intervention for Chinese children with autism and their parents: a randomised controlled trial
- A randomised controlled trial comparing MYmind with waitlist control among Chinese children with ADHD and their parents
香港中文大學公共衛生與初級保健學院的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04